CA
TEVA icon

Claris Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Claris Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,097
Closed -$19.8K – 1032
2024
Q3 		$19.8K Buy
+1,097
New +$19.2K 0.01% 187

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Claris Advisors's TEVA Position: Q4 2024 in Review

Claris Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2024, closing a stake of 1,097 shares — an estimated $19.8K sold.

Claris Advisors first reported a position in TEVA in Q3 2024 and held it in 1 quarter. The position peaked at $19.8K in Q3 2024. 585 funds tracked by Wall St. Rank hold TEVA as of Q4 2024.

  • Claris Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2024 after selling out during the quarter.
  • Claris Advisors sold 1,097 Teva Pharmaceutical Industries Limited shares in Q4 2024, an estimated $19.8K.
  • Claris Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q3 2024 and held it in 1 quarter.
  • Claris Advisors's Teva Pharmaceutical Industries Limited position peaked at $19.8K in Q3 2024.
  • 585 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.